The medical and recreational business of cannabis is coming together with the announcement of a new merger in the industry.
On Thursday (April 19) it was revealed that Hiku Brands (CSE:HIKU) and WeedMD (TSXV:WMD) would merge all businesses and assets in order to create a vertically integrated company. Continuing the momentum, predicted by experts, of consolidation alongside merger and acquisition deals.
The new entity is expected to trade on the TSX Venture Exchange, according to the announcement from the two companies.
“Upon completion of the transaction, existing Hiku and WeedMD shareholders will own approximately 51.75 [percent] and 48.25 percent] of the combined company, respectively, on a fully-diluted basis,” the announcement reads.
Consolidation continues in the Canadian cannabis market
As the industry in Canada moves closer towards legalization, experts have started to ask for a more thorough breakdown of the companies in the public space — specifically analyzing new metrics beyond production capacities.
Since Hiku’s play has been on targeting consumers with brands, Alan Gertner, CEO of Hiku, agrees with this vision and said during a conference call on Friday (April 20) that the new partnership will be able to capitalize on both retail and medical.
“Currently, a lot of the market, a lot of the focus in cannabis in Canada is solely on capacity and solely on the existing medical market. Together Hiku and WeedMD bring together differentiated players who focus on high value…” Gertner said.
“We are very excited to control our supply chain all the way through which will allow us to have brands that have a consistency and high supply behind them,” Keith Merker, chief financial officer of WeedMD, said during the call.
Production updates from WeedMD
During the question period of the call, analyst Neal Gilmer with Haywood Securities asked if the new company is considering accelerating the increase of production facility from WeedMD given the expected shortage of cannabis.
Merker answered by saying WeedMD is currently focused on the final stages of retrofitting a 5-acre lot of hybrid greenhouse growth. Additionally, the company is in discussions to work on the neighboring 7 acres, which he said would elevate the total capacity of the company to over 35 tonnes.
Gertner revealed the current plan for Hiku and now this new entity is to open between 20 and 30 retail cannabis stores across Canada. The management team of Hiku said it is confident in its ability to open these stores thanks in part to obtaining one of the four retail licenses in Manitoba.
During the call, Gertner suggested the opening of the retail market will allow Hiku to reach a blended retail price per gram of C$16 for cannabis. Gertner added he believes the relationships made with the consumer and the brands on day one of the legal recreational sales will last for the entire life of those customers.
The share price for WeedMD soared up since the announcement. In Friday trading the company’s stock saw a 3.45-percent increase, reaching a price of C$2.05 per share.
Hiku, on the other hand, decreased in value 1.19 percent on Friday. However, since the announcement was made on Thursday, and Hiku’s stock was taken out of a hold by the regulators, it has increased in value by 3.05 percent. The stock is currently priced at C$1.66.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: WeedMD and Hiku Brands are clients of the Investing News Network. This article is not paid-for content.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).